[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Expression Vectors Market by Host Type (Bacterial/E.Coli, Mammalian/CHO, Insect/Baculovirus, and Yeast), Application (Therapeutic, Research, and Industrial), End User (Pharmaceutical, Biotechnology, CROs & CMOs, and Academic Research) - Forecast to 2020

June 2015 | 138 pages | ID: E65F39D5ED4EN
MarketsandMarkets

US$ 3,955.00 US$ 5,650.00 -30 %
Offer valid until March 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The expression vectors market is expected to reach $317.1 million by 2020 from $242.7 million in 2015, growing at a CAGR of 5.5% from 2015 to 2020. The market is categorized on the basis of host type, application, end user, and region. The application market includes therapeutic, research, and industrial applications. The therapeutic applications segment is expected to grow at the highest CAGR in the coming five years.

Major factors contributing to the growth of the global expression vectors market include increasing demand of protein-based drugs (biologics); high prevalence of lifestyle diseases, infectious diseases, and genetic disorders; and increasing funding for protein research. For instance, in September 2014, AbCelex Technologies Inc., a privately held Canadian biotechnology company, received a venture capital fund of $1 million by Pinetree Capital Corporation for development of the company’s protein expression systems and antibody engineering techniques. Funding for protein research helps the expression vectors market to grow as it is an integral component of it.

The Asian expression vectors market is the fastest-growing market, globally. With huge man power and cost-effective manufacturing facilities, several market players are focusing on expanding their presence in the Asian countries. For instance, in November 2012, Promega Corporation (U.S.), a provider of expression vectors, opened a new facility in Shanghai, Shanghai Promega Life Science Center. This facility manufactures biological and chemical regents and instruments used in life science research and molecular diagnostics. Establishment of such facilities helps the local market with easy product availability and services.

Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the expression vectors market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on the product portfolios of the top players in the expression vectors market. The report analyzes this market by host type, application, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the expression vectors market
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the expression vectors market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various expression vector products across regions
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the expression vectors market
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
  1.3.1 MARKET SEGMENTATION
  1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN & DATA TRIANGULATION
2.3 KEY DATA FROM SECONDARY SOURCES
2.4 KEY DATA FROM PRIMARY SOURCES
2.5 KEY INDUSTRY INSIGHTS
2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 EXPRESSION VECTORS MARKET, BY HOST TYPE
4.2 EXPRESSION VECTORS MARKET, BY APPLICATION
4.3 EXPRESSION VECTORS MARKET, BY END USERS
4.4 EXPRESSION VECTORS MARKET, BY REGION

5 MARKET OVERVIEW

5.1 INTRODUCTION
  5.1.1 BY HOST TYPE
  5.1.2 BY APPLICATION
  5.1.3 BY END USER
  5.1.4 BY REGION
5.2 MARKET DYNAMICS
  5.2.1 MARKET DRIVERS
    5.2.1.1 High prevalence rate of lifestyle diseases, infectious diseases, and genetic disorders
    5.2.1.2 Increase in demand for protein-based therapeutic agents
    5.2.1.3 Funding for protein research
  5.2.2 MARKET RESTRAINT
    5.2.2.1 High cost of protein therapy
  5.2.3 OPPORTUNITY
    5.2.3.1 Developing countries
  5.2.4 CHALLENGE
    5.2.4.1 Sequestration cuts in the U.S.

6 EXPRESSION VECTORS MARKET, BY HOST TYPE

6.1 INTRODUCTION
6.2 BACTERIAL EXPRESSION VECTORS
  6.2.1 E.COLI EXPRESSION VECTORS
  6.2.2 OTHER BACTERIAL EXPRESSION VECTORS
6.3 MAMMALIAN EXPRESSION VECTORS
  6.3.1 CHO EXPRESSION VECTORS
  6.3.2 OTHER MAMMALIAN EXPRESSION VECTORS
6.4 INSECT EXPRESSION VECTORS
  6.4.1 BACULOVIRUS EXPRESSION VECTORS
  6.4.2 OTHER INSECT EXPRESSION VECTORS
6.5 YEAST EXPRESSION VECTORS
  6.5.1 K. LACTIS EXPRESSION VECTORS
  6.5.2 PICHIA PASTORIS EXPRESSION VECTORS
  6.5.3 SACCHAROMYCES CEREVISIAE EXPRESSION VECTORS
  6.5.4 OTHER YEAST EXPRESSION VECTORS
6.6 OTHER EXPRESSION VECTORS

7 EXPRESSION VECTORS MARKET, BY APPLICATION

7.1 INTRODUCTION
7.2 THERAPEUTIC APPLICATIONS
7.3 INDUSTRIAL APPLICATIONS
7.4 RESEARCH APPLICATIONS

8 EXPRESSION VECTORS MARKET, BY END USER

8.1 INTRODUCTION
8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
8.3 CROS AND CMOS
8.4 ACADEMIC RESEARCH INSTITUTES
8.5 OTHER END USERS

9 GLOBAL EXPRESSION VECTORS MARKET, BY REGION

9.1 INTRODUCTION
9.2 NORTH AMERICA
  9.2.1 U.S.
  9.2.2 CANADA
9.3 EUROPE
9.4 ASIA
9.5 REST OF THE WORLD (ROW)

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS
10.3 COMPETITIVE SITUATION AND TRENDS
  10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
  10.3.2 EXPANSIONS
  10.3.3 ACQUISITIONS
  10.3.4 NEW PRODUCT LAUNCHES

11 COMPANY PROFILES

11.1 INTRODUCTION
11.2 MERCK MILLIPORE (A SUBSIDIARY OF MERCK KGAA)
  11.2.1 BUSINESS OVERVIEW
  11.2.2 PRODUCT OFFERINGS
  11.2.3 RECENT DEVELOPMENTS
  11.2.4 MNM VIEW
11.3 THERMO FISHER SCIENTIFIC, INC.
  11.3.1 BUSINESS OVERVIEW
  11.3.2 PRODUCT OFFERINGS
  11.3.3 RECENT DEVELOPMENTS
  11.3.4 MNM VIEW
11.4 SIGMA-ALDRICH CORPORATION
  11.4.1 BUSINESS OVERVIEW
  11.4.2 PRODUCT OFFERINGS
  11.4.3 RECENT DEVELOPMENTS
  11.4.4 MNM VIEW
11.5 PROMEGA CORPORATION
  11.5.1 BUSINESS OVERVIEW
  11.5.2 PRODUCT OFFERINGS
  11.5.3 RECENT DEVELOPMENTS
  11.5.4 MNM VIEW
11.6 CLONTECH LABORATORIES, INC.
  11.6.1 BUSINESS OVERVIEW
  11.6.2 PRODUCT OFFERINGS
  11.6.3 RECENT DEVELOPMENTS
  11.6.4 MNM VIEW
11.7 AGILENT TECHNOLOGIES
  11.7.1 BUSINESS OVERVIEW
  11.7.2 PRODUCT OFFERINGS
  11.7.3 RECENT DEVELOPMENTS
11.8 BIO-RAD LABORATORIES, INC.
  11.8.1 BUSINESS OVERVIEW
  11.8.2 PRODUCT OFFERINGS
  11.8.3 RECENT DEVELOPMENTS
11.9 DNA2.0, INC.
  11.9.1 BUSINESS OVERVIEW
  11.9.2 PRODUCT OFFERINGS
  11.9.3 RECENT DEVELOPMENTS
11.10 NEW ENGLAND BIOLABS (NEB)
  11.10.1 BUSINESS OVERVIEW
  11.10.2 PRODUCT OFFERINGS
  11.10.3 RECENT DEVELOPMENTS
11.11 QIAGEN
  11.11.1 BUSINESS OVERVIEW
  11.11.2 PRODUCT OFFERINGS
  11.11.3 RECENT DEVELOPMENTS

12 APPENDIX

12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS

LIST OF TABLES

Table 1 INCREASE IN DEMAND FOR PROTEIN-BASED THERAPEUTIC AGENTS IS BOOSTING MARKET GROWTH
Table 2 HIGH COST OF PROTEIN THERAPY ACTS AS A RESTRAINT TO THE GROWTH OF THE EXPRESSION VECTORS MARKET
Table 3 DEVELOPING COUNTRIES TO OFFER AN ARRAY OF OPPORTUNITIES
Table 4 SEQUESTRATION CUTS IN THE U.S. POSE SIGNIFICANT CHALLENGES TO MARKET GROWTH
Table 5 EXPRESSION VECTORS MARKET SIZE, BY HOST TYPE, 2013–2020 ($MILLION)
Table 6 BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 7 BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 8 NORTH AMERICA: BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 9 E.COLI EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 10 NORTH AMERICA: E.COLI EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 11 OTHER BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 12 NORTH AMERICA: OTHER BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 13 MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 14 MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 15 NORTH AMERICA: MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 16 CHO EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 17 NORTH AMERICA: CHO EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 18 OTHER MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 19 NORTH AMERICA: OTHER MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 20 INSECT EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 21 INSECT EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 22 NORTH AMERICA: INSECT EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 23 BACULOVIRUS EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 24 NORTH AMERICA: BACULOVIRUS EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 25 OTHER INSECT EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($THOUSAND)
Table 26 NORTH AMERICA: OTHER INSECT EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($THOUSAND)
Table 27 YEAST EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 28 YEAST EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 29 NORTH AMERICA: YEAST EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 30 K. LACTIS EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 31 NORTH AMERICA: K. LACTIS EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 32 P. PASTORIS EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 33 NORTH AMERICA: P. PASTORIS EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 34 S. CEREVISIAE EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 35 NORTH AMERICA: S. CEREVISIAE EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 36 OTHER YEAST EXPRESSION VECTORS, BY REGION, 2013–2020 ($THOUSAND)
Table 37 NORTH AMERICA: OTHER YEAST EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($THOUSAND)
Table 38 OTHER EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 39 NORTH AMERICA: OTHER EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
Table 40 EXPRESSION VECTORS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
Table 41 EXPRESSION VECTORS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY REGION, 2013-2020 ($MILLION)
Table 42 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 ($MILLION)
Table 43 EXPRESSION VECTORS MARKET SIZE FOR INDUSTRIAL APPLICATIONS, BY REGION, 2013-2020 ($MILLION)
Table 44 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2013-2020 ($MILLION)
Table 45 EXPRESSION VECTORS MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2013-2020 ($MILLION)
Table 46 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE FOR RESEARCH APPLICATIONS, BY COUNTRY, 2013-2020 ($MILLION)
Table 47 EXPRESSION VECTORS MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
Table 48 EXPRESSION VECTORS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 ($MILLION)
Table 49 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 ($MILLION)
Table 50 EXPRESSION VECTORS MARKET SIZE FOR CROS AND CMOS, BY REGION, 2013-2020 ($MILLION)
Table 51 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE FOR CROS AND CMOS, BY COUNTRY, 2013-2020 ($MILLION)
Table 52 EXPRESSION VECTORS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2013-2020 ($MILLION)
Table 53 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2013-2020 ($MILLION)
Table 54 EXPRESSION VECTORS MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 ($MILLION)
Table 55 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 ($MILLION)
Table 56 EXPRESSION VECTORS MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 57 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE, BY COUNTRY, 2013–2020 ($MILLION)
Table 58 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE, BY HOST TYPE, 2013–2020 ($MILLION)
Table 59 NORTH AMERICA: BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 60 NORTH AMERICA: MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 61 NORTH AMERICA: YEAST EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 62 NORTH AMERICA: INSECT EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 63 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE, BY APPLICATION, 2013–2020 ($MILLION)
Table 64 NORTH AMERICA: EXPRESSION VECTORS MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 65 U.S.: EXPRESSION VECTORS MARKET SIZE, BY HOST TYPE, 2013–2020 ($MILLION)
Table 66 U.S.: BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 67 U.S.: MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 68 U.S.: YEAST EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 69 U.S.: INSECT EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 70 U.S.: EXPRESSION VECTORS MARKET SIZE, BY APPLICATION, 2013–2020 ($MILLION)
Table 71 U.S.: EXPRESSION VECTORS MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 72 CANADA: EXPRESSION VECTORS MARKET SIZE, BY HOST TYPE, 2013–2020 ($MILLION)
Table 73 CANADA: BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 74 CANADA: MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 75 CANADA: YEAST EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 76 CANADA: INSECT EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 77 CANADA: EXPRESSION VECTORS MARKET SIZE, BY APPLICATION, 2013–2020 ($MILLION)
Table 78 CANADA: EXPRESSION VECTORS MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 79 EUROPE: EXPRESSION VECTORS MARKET SIZE, BY HOST TYPE, 2013–2020 ($MILLION)
Table 80 EUROPE: BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 81 EUROPE: MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 82 EUROPE: YEAST EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 83 EUROPE: INSECT EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 84 EUROPE: EXPRESSION VECTORS MARKET SIZE, BY APPLICATION, 2013–2020 ($MILLION)
Table 85 EUROPE: EXPRESSION VECTORS MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 86 ASIA: EXPRESSION VECTORS MARKET SIZE, BY HOST TYPE, 2013–2020 ($MILLION)
Table 87 ASIA: BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 88 ASIA: MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 89 ASIA: YEAST EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 90 ASIA: INSECT EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
Table 91 ASIA: EXPRESSION VECTORS MARKET SIZE, BY APPLICATION, 2013–2020 ($MILLION)
Table 92 ASIA: EXPRESSION VECTORS MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 93 ROW: EXPRESSION VECTORS MARKET SIZE, BY HOST TYPE, 2013–2020 ($MILLION)
Table 94 ROW: BACTERIAL EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 95 ROW: MAMMALIAN EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 96 ROW: YEAST EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 97 ROW: INSECT EXPRESSION VECTORS MARKET SIZE, BY TYPE, 2013–2020 ($MILLION)
Table 98 ROW: EXPRESSION VECTORS MARKET SIZE, BY APPLICATION, 2013–2020 ($MILLION)
Table 99 ROW: EXPRESSION VECTORS MARKET SIZE, BY END USER, 2013–2020 ($MILLION)
Table 100 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2012–2015
Table 101 EXPANSIONS, 2012–2015
Table 102 ACQUISITIONS, 2013–2014
Table 103 NEW PRODUCT LAUNCHES, 2012–2014

LIST OF FIGURES

Figure 1 RESEARCH DESIGN
Figure 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
Figure 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
Figure 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 EXPRESSION VECTORS MARKET SNAPSHOT, BY HOST TYPE (2015 VS. 2020)
Figure 7 CROS AND CMOS FORM THE FASTEST-GROWING END-USER SEGMENT
Figure 8 EXPRESSION VECTORS MARKET, BY APPLICATION (2015-2020): THERAPEUTIC APPLICATIONS TO WITNESS HIGHEST GROWTH
Figure 9 GLOBAL EXPRESSION VECTORS MARKET, BY REGION: NORTH AMERICA EXPECTED TO HOLD THE LARGEST SHARE IN 2015
Figure 10 MAMMALIAN EXPRESSION VECTORS MARKET TO GROW AT THE HIGHEST CAGR FROM 2015 TO 2020
Figure 11 BACTERIAL, MAMMALIAN, AND INSECT EXPRESSION VECTORS: MAJOR MARKET SEGMENTS IN 2015
Figure 12 THERAPEUTIC APPLICATIONS TO WITNESS HIGHEST GROWTH RATE IN THE FORECAST PERIOD
Figure 13 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO COMMAND THE LARGEST SHARE IN 2015
Figure 14 ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD
Figure 15 EXPRESSION VECTORS MARKET SEGMENTATION: BY HOST TYPE
Figure 16 EXPRESSION VECTORS MARKET SEGMENTATION: BY APPLICATION
Figure 17 EXPRESSION VECTORS MARKET SEGMENTATION: BY END USER
Figure 18 EXPRESSION VECTORS MARKET SEGMENTATION: BY REGION
Figure 19 INCREASE IN DEMAND FOR PROTEIN-BASED DRUGS TO PROPEL MARKET GROWTH
Figure 20 MAMMALIAN EXPRESSION VECTORS TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD
Figure 21 K. LACTIS EXPRESSION VECTORS TO WITNESS HIGHEST GROWTH
Figure 22 THERAPEUTIC APPLICATIONS: FASTEST-GROWING APPLICATION SEGMENT
Figure 23 THERAPEUTIC APPLICATIONS: ASIA TO SHOW HIGHEST GROWTH
Figure 24 END-USER BASE: EXPRESSION VECTORS MARKET
Figure 25 CROS AND CMOS, A HIGH-GROWTH END-USER SEGMENT IN THE MARKET
Figure 26 ASIA, AN ATTRACTIVE DESTINATION FOR ALL APPLICATIONS IN THE EXPRESSION VECTORS MARKET
Figure 27 NORTH AMERICA HOLDS THE LARGEST SHARE OF THE GLOBAL EXPRESSION VECTORS MARKET (2015)
Figure 28 EUROPEAN EXPRESSION VECTORS MARKET SNAPSHOT
Figure 29 ASIAN EXPRESSION VECTORS MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 30 ROW EXPRESSION VECTORS MARKET SNAPSHOT
Figure 31 MAJOR PLAYERS PURSUED INORGANIC GROWTH STRATEGIES BETWEEN 2012 & 2015
Figure 32 GLOBAL EXPRESSION VECTORS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
Figure 33 MARKET EVOLUTION FRAMEWORK: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS & EXPANSIONS FUELLED MARKET GROWTH
Figure 34 BATTLE FOR MARKET SHARE: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS WAS THE KEY STRATEGY
Figure 35 GEOGRAPHIC REVENUE MIX OF KEY MARKET PLAYERS
Figure 36 MERCK MILLIPORE: COMPANY SNAPSHOT
Figure 37 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
Figure 38 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
Figure 39 TAKARA BIO, INC.: COMPANY SNAPSHOT
Figure 40 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
Figure 41 BIO-RAD LABORATORIES: COMPANY SNAPSHOT
Figure 42 QIAGEN: COMPANY SNAPSHOT


More Publications